Moreover, there was a significant progressive increase in TRPC-1 in SSc-MVECs challenged with sKl (p < 0.05 for either 24-hour or 48-hour treatment versus basal condition) (Fig. 7b). The gene discussed is TRPC1; the disease is systemic sclerosis.